Table 1.
Clinical characteristics and thrombus compositions.
| Thrombus migration (n = 11) | No thrombus migration (n = 53) | p value | |
|---|---|---|---|
| Age, years, median, range | 75, 70–78 | 72, 59–80.5 | 0.27 |
| Female, n (%) | 5 (45.5) | 33 (62.3) | 0.30 |
| Drip ’n ship, n (%) | 10 (90.9) | 22 (41.5) | 0.003a |
| IV tPA, n (%) | 8 (72.7) | 36 (67.9) | 0.75 |
| Symptom onset to groin puncture, min (IQR) | 230 (217.5–240) | 170 (150.50–251.25) | 0.36 |
| Groin puncture to successful recanalization, min (IQR) | 40 (25–60) | 40 (20.5–65.57) | 0.71 |
| Stroke cause (TOAST), n (%) | 1.000 | ||
| 1 = arterioembolic | 1 (9.1) | 8 (15.1) | |
| 2 = cardioembolic | 7 (63.6) | 28 (52.8) | |
| 4 = other determined cause | 0 | 2 (3.8) | |
| 5 = cryptogenic | 3 (27.3) | 15 (28.3) | |
| Thrombus composition, %, median, range | |||
| F/P, %a | 54, 33–65 | 57, 49–69 | 0.24 |
| RBC, %a | 41, 29–60 | 37, 23–45.5 | 0.22 |
| WBC, %a | 5, 4–7 | 5, 4–7 | 0.96 |
| RBC-rich, n (%) | 4 (36.4) | 3 (5.7) | 0.003a |
IV rtPA: intravenous tissue-type plasminogen activator; IQR: interquartile range; TOAST: Trial of Org 10172 in Acute Stroke Treatment; F/P: fibrin/platelet; RBC: red blood cells; WBC: white blood cells; RBC-rich, clots with > 60% RBC.
a
p < 0.01.